VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 214 filers reported holding VERACYTE INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,291,861 | -34.4% | 102,636 | -25.1% | 0.00% | -25.0% |
| Q2 2023 | $3,492,420 | +120.9% | 137,119 | +105.8% | 0.00% | +100.0% |
| Q4 2022 | $1,581,343 | +229.4% | 66,639 | +130.7% | 0.00% | +100.0% |
| Q3 2022 | $480,000 | +91.2% | 28,891 | +129.1% | 0.00% | – |
| Q2 2022 | $251,000 | -74.0% | 12,610 | -64.0% | 0.00% | -100.0% |
| Q1 2022 | $965,000 | -32.4% | 34,987 | +1.0% | 0.00% | 0.0% |
| Q4 2021 | $1,427,000 | +8.8% | 34,628 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $1,312,000 | -61.2% | 32,826 | -47.8% | 0.00% | -75.0% |
| Q1 2021 | $3,379,000 | +61.1% | 62,866 | +46.7% | 0.00% | +33.3% |
| Q4 2020 | $2,097,000 | +267.9% | 42,854 | +144.4% | 0.00% | +200.0% |
| Q3 2020 | $570,000 | -62.7% | 17,536 | -70.3% | 0.00% | -66.7% |
| Q2 2020 | $1,529,000 | +1.9% | 59,016 | -4.3% | 0.00% | 0.0% |
| Q1 2020 | $1,500,000 | +302.1% | 61,696 | +362.3% | 0.00% | +200.0% |
| Q4 2019 | $373,000 | – | 13,346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |